Welcome to our dedicated page for Megola news (Ticker: MGON), a resource for investors and traders seeking the latest updates and insights on Megola stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Megola's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Megola's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Megola Inc. (OTC-PINK:MGON) announced a significant milestone with the signing of an Exclusive Global Supply Agreement for its liquid glass screen protection technology. This deal, projected to generate
Megola Inc. (OTC PINK: MGON) has announced the acquisition of a Specialty Coffee product line and Sio2 Proteksol for seed and foliage coating for $15,000 each, payable in Series F Preferred Stock. The coffee line includes health-focused products such as Weight Loss Coffee and CBD-infused Coffee, all produced with biodegradable packaging. The Sio2 Proteksol coating is an environmentally friendly solution aimed at enhancing plant growth. The company is in negotiations for additional acquisitions, signaling strategic growth in the eco-friendly sector.
Summary not available.
Megola, Inc. (OTC PINK:MGON) has reduced its outstanding common shares by 19,500,000, bringing the total from 254,595,060 to 235,095,060. CEO Robert Gardiner has initiated an investigation into past stock issuances that may have been invalid. The company is also reviewing over 20 million common shares in certificate form for potential cancellation. This move is part of Megola's broader strategy to enhance shareholder value and ensure compliance after recent corporate restructuring efforts.
COVID delays have ended, and Megola Inc. (MGON) is advancing its plans with EPA and FDA certifications. The company, focused on health technologies, has diversified its product portfolio. Megola aims to launch next-generation antimicrobial products and CBD-infused items, enhancing customer health and environmental sustainability. The company feels optimistic about finalizing acquisitions and product certifications in the upcoming quarters. Noteworthy product lines include antimicrobial surfaces, CBD products, and fire-related solutions. CEO Bob Gardiner reassures stakeholders of the commitment to quality and market readiness.
Megola, Inc. (OTC:MGON) announces the expansion of its Balanced2Day brand into the CBD market, offering a range of premium hemp extract products. The new line includes tinctures, gummies, muscle gel, relief salve, cooling cream, moisturizing lotion, and pet products, launching between April and June. The CBD market is projected to grow at a CAGR of 52.7%, driven by increasing awareness of its health benefits. CEO Robert Gardiner emphasizes the company's commitment to quality and affordability, with all products being pesticide-free and legal in all 50 states.